#4D6D88_Small Cover_March-April 2024 DRA Journal

In this exclusive Show Preview Issue, we present the IDEM Singapore 2024 Q&A Forum featuring key opinion leaders; their clinical insights covering orthodontics and dental implantology; plus a sneak peek at the products and technologies set to take center stage at the event. 

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study

A recent publication in The International Journal of Oral & Maxillofacial Implants has highlighted the superiority of ZimVie Dental’s Puros Cancellous Particulate Allograft over other competitive freeze-dried allograft solutions in terms of physicochemical properties and ability to support bone formation.

The article compared the effects of different tissue processing methods on the properties of allografts, including Puros Cancellous Particulate Allograft, Creos™, OraGraft®, and MinerOss™.

Surface Area 100 times higher than Freeze-dried Allografts

The study showed that the surface area of Puros Cancellous Particulate Allograft was 100 times higher than that of the freeze-dried allografts, which is critical for implant dentistry, as the strength and health of grafted sites are crucial for implant success.


Click to Visit website of India's Leading Manufacturer of World Class Dental Materials, Exported to 90+ Countries.


 

The study also found that the collagen microstructure and the size of individual fibers of Puros Cancellous Particulate Allograft were almost identical to those of unprocessed human bone tissue.

This resulted in a significantly higher response from a specific type of stromal cells (from bone marrow) in vitro (hBMSC).


Click to visit website: The All-in-one patient centric cloud solution for intelligent radiograph detection and diagnosis.


 

Well-documented Clinical History

Puros Cancellous Particulate Allograft has a well-documented clinical history and is an easy-to-handle choice for predictable bone reconstruction.

It acts as an osteoconductive scaffold for new bone formation and is processed using the Tutoplast Tissue Sterilization Process, which has over 50 years of successful clinical use and zero incidents of implant-associated infections.

ZimVie Dental’s Puros portfolio is supported by over 300 peer-reviewed scientific papers, making it the gold standard in allograft bone substitutes.

About ZimVie Inc.

ZimVie Inc. is a global life sciences leader in the dental and spine markets that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to treat a wide range of spine pathologies and support dental tooth replacement and restoration procedures.

The company was founded in March 2022 as an independent, publicly traded spin-off of the Dental and Spine business units of Zimmer Biomet.

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.